These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26113531)

  • 41. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.
    Mullighan CG; Goorha S; Radtke I; Miller CB; Coustan-Smith E; Dalton JD; Girtman K; Mathew S; Ma J; Pounds SB; Su X; Pui CH; Relling MV; Evans WE; Shurtleff SA; Downing JR
    Nature; 2007 Apr; 446(7137):758-64. PubMed ID: 17344859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid Malignancies.
    Mesuraca M; Chiarella E; Scicchitano S; Codispoti B; Giordano M; Nappo G; Bond HM; Morrone G
    Biomed Res Int; 2015; 2015():165238. PubMed ID: 26788497
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PAX5 promotes pre-B cell proliferation by regulating the expression of pre-B cell receptor and its downstream signaling.
    Xue K; Song J; Yang Y; Li Z; Wu C; Jin J; Li W
    Mol Immunol; 2016 May; 73():1-9. PubMed ID: 27016671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The distal V(H) gene cluster of the Igh locus contains distinct regulatory elements with Pax5 transcription factor-dependent activity in pro-B cells.
    Ebert A; McManus S; Tagoh H; Medvedovic J; Salvagiotto G; Novatchkova M; Tamir I; Sommer A; Jaritz M; Busslinger M
    Immunity; 2011 Feb; 34(2):175-87. PubMed ID: 21349430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Zfp521 promotes B-cell viability and cyclin D1 gene expression in a B cell culture system.
    Al Dallal S; Wolton K; Hentges KE
    Leuk Res; 2016 Jul; 46():10-7. PubMed ID: 27107743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice.
    Jamrog L; Chemin G; Fregona V; Coster L; Pasquet M; Oudinet C; Rouquié N; Prade N; Lagarde S; Cresson C; Hébrard S; Nguyen Huu NS; Bousquet M; Quelen C; Brousset P; Mancini SJC; Delabesse E; Khamlichi AA; Gerby B; Broccardo C
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10357-10362. PubMed ID: 30257940
    [No Abstract]   [Full Text] [Related]  

  • 47. Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia.
    Nebral K; Denk D; Attarbaschi A; König M; Mann G; Haas OA; Strehl S
    Leukemia; 2009 Jan; 23(1):134-43. PubMed ID: 19020546
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pax5--a critical inhibitor of plasma cell fate.
    Nera KP; Lassila O
    Scand J Immunol; 2006 Sep; 64(3):190-9. PubMed ID: 16918686
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel PAX5 rearrangement in TCF3-PBX1 acute lymphoblastic leukemia: a case report.
    Barbosa TC; Lopes BA; Blunck CB; Mansur MB; Deyl AVS; Emerenciano M; Pombo-de-Oliveira MS
    BMC Med Genomics; 2018 Dec; 11(1):122. PubMed ID: 30563523
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression and production of aberrant PAX5 with deletion of exon 8 in B-lineage acute lymphoblastic leukaemia of children.
    Sadakane Y; Zaitsu M; Nishi M; Sugita K; Mizutani S; Matsuzaki A; Sueoka E; Hamasaki Y; Ishii E
    Br J Haematol; 2007 Jan; 136(2):297-300. PubMed ID: 17129225
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential regulation of sense and antisense promoter activity at the Csf1R locus in B cells by the transcription factor PAX5.
    Ingram RM; Valeaux S; Wilson N; Bouhlel MA; Clarke D; Krüger I; Kulu D; Suske G; Philipsen S; Tagoh H; Bonifer C
    Exp Hematol; 2011 Jul; 39(7):730-40.e1-2. PubMed ID: 21549805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FOXP1 and PAX5 are rare but recurrent translocations partners in acute lymphoblastic leukemia.
    Put N; Deeren D; Michaux L; Vandenberghe P
    Cancer Genet; 2011 Aug; 204(8):462-4. PubMed ID: 21962897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Developmentally regulated higher-order chromatin interactions orchestrate B cell fate commitment.
    Boya R; Yadavalli AD; Nikhat S; Kurukuti S; Palakodeti D; Pongubala JMR
    Nucleic Acids Res; 2017 Nov; 45(19):11070-11087. PubMed ID: 28977418
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early B cell factor 1 regulates B cell gene networks by activation, repression, and transcription- independent poising of chromatin.
    Treiber T; Mandel EM; Pott S; Györy I; Firner S; Liu ET; Grosschedl R
    Immunity; 2010 May; 32(5):714-25. PubMed ID: 20451411
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PAX5 deletion is common and concurrently occurs with CDKN2A deletion in B-lineage acute lymphoblastic leukemia.
    Kim M; Choi JE; She CJ; Hwang SM; Shin HY; Ahn HS; Yoon SS; Kim BK; Park MH; Lee DS
    Blood Cells Mol Dis; 2011 Jun; 47(1):62-6. PubMed ID: 21549623
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia.
    Marincevic-Zuniga Y; Zachariadis V; Cavelier L; Castor A; Barbany G; Forestier E; Fogelstrand L; Heyman M; Abrahamsson J; Lönnerholm G; Nordgren A; Syvänen AC; Nordlund J
    Haematologica; 2016 Jan; 101(1):e20-3. PubMed ID: 26494837
    [No Abstract]   [Full Text] [Related]  

  • 57. Single-cell analysis identifies dynamic gene expression networks that govern B cell development and transformation.
    Lee RD; Munro SA; Knutson TP; LaRue RS; Heltemes-Harris LM; Farrar MA
    Nat Commun; 2021 Nov; 12(1):6843. PubMed ID: 34824268
    [TBL] [Abstract][Full Text] [Related]  

  • 58. B-cell transcription factor expression and immunoglobulin gene rearrangement frequency in acute myeloid leukemia with t(8;21)(q22;q22).
    Johnson RC; Ma L; Cherry AM; Arber DA; George TI
    Am J Clin Pathol; 2013 Sep; 140(3):355-62. PubMed ID: 23955454
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AID.
    Rodríguez-Hernández G; Opitz FV; Delgado P; Walter C; Álvarez-Prado ÁF; González-Herrero I; Auer F; Fischer U; Janssen S; Bartenhagen C; Raboso-Gallego J; Casado-García A; Orfao A; Blanco O; Alonso-López D; Rivas JL; Tena-Dávila SG; Müschen M; Dugas M; Criado FJG; Cenador MBG; Vicente-Dueñas C; Hauer J; Ramiro AR; Sanchez-Garcia I; Borkhardt A
    Nat Commun; 2019 Dec; 10(1):5563. PubMed ID: 31804490
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunologic regulation of bone development.
    Horowitz MC; Lorenzo JA
    Adv Exp Med Biol; 2007; 602():47-56. PubMed ID: 17966387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.